197 related articles for article (PubMed ID: 20655375)
1. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Int J Pharm; 2010 Oct; 398(1-2):190-203. PubMed ID: 20655375
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Cancer Nanotechnol; 2012; 3(1-6):65-81. PubMed ID: 26069496
[TBL] [Abstract][Full Text] [Related]
3. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vitro cytotoxicity assay of curcumin loaded solid lipid nanoparticle in IMR32 neuroblastoma cell line.
Rahman MH; Ramanathan M; Sankar V
Pak J Pharm Sci; 2014 Sep; 27(5):1281-5. PubMed ID: 25176384
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
6. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
[TBL] [Abstract][Full Text] [Related]
7. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
[TBL] [Abstract][Full Text] [Related]
8. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
9. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
10. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
11. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
12. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
13. Formulation of the novel structure curcumin derivative-loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening
Li K; Pi C; Wen J; He Y; Yuan J; Shen H; Zhao W; Zeng M; Song X; Lee RJ; Wei Y; Zhao L
Drug Deliv; 2022 Dec; 29(1):2044-2057. PubMed ID: 35775475
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
Sharma JB; Bhatt S; Saini V; Kumar M
Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
[No Abstract] [Full Text] [Related]
15. Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells.
Kumar SS; Mahesh A; Mahadevan S; Mandal AB
Biochim Biophys Acta; 2014 Jun; 1840(6):1913-22. PubMed ID: 24440669
[TBL] [Abstract][Full Text] [Related]
16. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
18. Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line.
Zhu R; Wu X; Xiao Y; Gao B; Xie Q; Liu H; Wang S
Cancer Biother Radiopharm; 2013 Oct; 28(8):579-87. PubMed ID: 23808828
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
20. Curcumin loaded poly(2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid--in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells.
Kumar SS; Surianarayanan M; Vijayaraghavan R; Mandal AB; MacFarlane DR
Eur J Pharm Sci; 2014 Jan; 51():34-44. PubMed ID: 24012589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
